[1S04a] 14. Chemical Biotechnology - Part 2

2:00 PM - 2:30 PM JST(5:00 AM - 5:30 AM UTC)

[1Chemi-07-KL] Reducing tumor heterogeneity with TTFields prevents glioblastoma recurrence by concurrently inhibiting the membrane form of the CLIC1 protein

○Michele Mazzanti¹, Francesca Cianci¹, Elisa Meraviglia¹, Guido Rey¹, Antonio Maria Polito¹, Sara Torabi¹, Stefania Castiglione¹, Chiara Agnese Mercurio¹, Ditmar Krex⁵, federica Barbieri², Tullio Florio^2,3, Martin Gabay⁴, Tatiana Vorobyov⁴, Kerem Wainer Katsir⁴, Yaara Porat⁴, Roni Blat⁴, Ori Braten⁴, Itai Tzchori⁴ (1. Department Bioscience, University of Milano (Italy), 2. Department of Internal Medicine, University of Genova (Italy), 3. IRCS Ospedale Policlinico San Martino (Italy), 4. Novocure GmbH (Switzerland), 5. Technische Universität Dresden (Germany))

Keywords:

Glioblastoma,Cancer heterogeneity,Metabolic reprogramming,Treatment resistance,Drug repurposing

Password required to view

Password required to view

Log in

or